Market Overview The US antimicrobial therapeutics market is diversifying as antifungal resistance concerns prompt expanded investment in next-generation azoles and echinocandins. The US Antimicrobial Therapeutics Market is projected to advance through 2030, driven by increasing invasive candidiasis in ICU settings, rising azole-resistant Aspergillus infections, growing transplant recipient...